News
Burrill & Company Leads $12.9 Million Series E Round In WhiteGlove Health April 16, 2012 | Press Release
Burrill & Company Leads $16.5 Million Round in WaveTec Vision to Commercialize Its Cataract Surgery Breakthrough April 16, 2012 | Press Release
Burrill & Company Leads ADMA Biologics’ $17.5 Million Private Placement April 15, 2012 | Press Release
See all NewsInternational

Sergey Axenovich
Senior Associate, RussiaSergey joined Burrill Merchant Banking in 2007. Before joining Burrill & Company, Sergey managed the cancer drug discovery program and associated corporate collaborations at PPD. He began his research career at Genome Therapeutics. Subsequently, he received his MBA from the University of California, Berkeley Haas School of Business. Sergey has a Ph.D. in Molecular Genetics from the University of Illinois, Chicago and an undergraduate degree in Molecular Biology from Moscow University.

